Treatment Response
Impression
- Patient’s NT-proBNP has decreased as she continues to titrate Orenitram.
- 6MWD, FC, and symptoms have improved from previous visit.
- Echo shows improvements in RV function; RHC ordered to comprehensively evaluate risk status and assess response to treatment.
Hemodynamic Assessment
| Parameter | Value |
|---|---|
| RAP | 8.5 mm Hg |
| mPAP | 38 mm Hg |
| sPAP | 53 mm Hg |
| dPAP | 30 mm Hg |
| PAWP | 6 mm Hg |
| PVR | 6.9 WU |
| CO | 4.6 L/min |
| CI | 2.7 L/min/m2 |
| SvO2 | 62% |